Mitchell & Pahl Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Sell
175
-5
-3% -$5.9K 0.07% 146
2026
Q2
$216K Buy
+180
New +$184K 0.08% 148

Other funds holding LLY

Mitchell & Pahl Private Wealth's LLY Position: Q3 2026 in Review

Mitchell & Pahl Private Wealth reduced its Eli Lilly (LLY) stake by 2.8% in Q3 2026, selling an estimated $5.9K and leaving 175 shares worth $202K. The position accounts for 0.07% of the portfolio, ranked #146.

Mitchell & Pahl Private Wealth first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $216K in Q2 2026. 1,212 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Mitchell & Pahl Private Wealth held 175 shares of Eli Lilly worth $202K as of Q3 2026.
  • Mitchell & Pahl Private Wealth sold 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
  • Eli Lilly made up 0.07% of Mitchell & Pahl Private Wealth's portfolio in Q3 2026, its #146 holding.
  • Mitchell & Pahl Private Wealth first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • Mitchell & Pahl Private Wealth's Eli Lilly position peaked at $216K in Q2 2026.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.